发布求助
文献互助 智能选刊 最新文献

Actualites Pharmaceutiques最新文献

筛选
英文 中文
Évaluez-vous ! Évaluez-vous ！
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.016
{"title":"Évaluez-vous !","authors":"","doi":"10.1016/j.actpha.2024.07.016","DOIUrl":"10.1016/j.actpha.2024.07.016","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sensibiliser et participer à la vaccination à l’officine 提高药房对疫苗接种的认识并参与其中
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.006
{"title":"Sensibiliser et participer à la vaccination à l’officine","authors":"","doi":"10.1016/j.actpha.2024.07.006","DOIUrl":"10.1016/j.actpha.2024.07.006","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le daridorexant (Quviviq®) pour le traitement de l’insomnie chronique 用于治疗慢性失眠的 Daridorexant (Quviviq®)
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.002
{"title":"Le daridorexant (Quviviq®) pour le traitement de l’insomnie chronique","authors":"","doi":"10.1016/j.actpha.2024.07.002","DOIUrl":"10.1016/j.actpha.2024.07.002","url":null,"abstract":"<div><div>Quviviq® est un nouveau médicament permettant de traiter les insomnies. Le daridorexant, son principe actif, est un antagoniste des récepteurs de l’orexine, agissant à la fois sur les récepteurs de l’orexine 1 et 2. Ce premier antagoniste double des récepteurs de l’orexine est une molécule au mécanisme d’action innovant ayant pour objectif d’inhiber les systèmes d’éveil.</div></div><div><div>Quviviq® is a new drug for treating insomnia. Its active ingredient, daridorexant, is an orexin receptor antagonist, acting on both orexin-1 and 2 receptors. This first dual orexin receptor antagonist is a molecule with an innovative mechanism of action designed to inhibit arousal systems.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Savoir identifier les symptômes de l’endométriose, une priorité 了解如何识别子宫内膜异位症的症状是当务之急
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.001
{"title":"Savoir identifier les symptômes de l’endométriose, une priorité","authors":"","doi":"10.1016/j.actpha.2024.07.001","DOIUrl":"10.1016/j.actpha.2024.07.001","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prévention des infections à virus respiratoire syncytial 预防呼吸道合胞病毒感染
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.008
{"title":"Prévention des infections à virus respiratoire syncytial","authors":"","doi":"10.1016/j.actpha.2024.07.008","DOIUrl":"10.1016/j.actpha.2024.07.008","url":null,"abstract":"<div><div>Le virus respiratoire syncytial est responsable d’infections des voies aériennes supérieures et inférieures potentiellement graves à tous les âges de la vie. Des comportements simples et efficaces axés sur le respect des règles d’hygiène limitent la transmission du virus qui est à l’origine, entre autres, de la bronchiolite. La mise à disposition et le développement de nouveaux traitements préventifs à base d’anticorps monoclonaux ou fondés sur la vaccination permettront d’assurer la protection de l’ensemble des populations fragiles.</div></div><div><div>The respiratory syncytial virus is responsible for potentially serious infections of the upper and lower airways at all ages. Simple, effective hygiene practices limit transmission of the virus that causes bronchiolitis, among other diseases. The availability and development of new preventive treatments based on monoclonal antibodies or vaccination will ensure the protection of all fragile populations.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
actualités santé publique 公共卫生新闻
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.09.018
{"title":"actualités santé publique","authors":"","doi":"10.1016/j.actpha.2024.09.018","DOIUrl":"10.1016/j.actpha.2024.09.018","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Produits 产品
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.09.020
{"title":"Produits","authors":"","doi":"10.1016/j.actpha.2024.09.020","DOIUrl":"10.1016/j.actpha.2024.09.020","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunosuppresseur et vaccin contre la varicelle et le zona 免疫抑制剂和预防水痘和带状疱疹的疫苗
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.004
{"title":"Immunosuppresseur et vaccin contre la varicelle et le zona","authors":"","doi":"10.1016/j.actpha.2024.07.004","DOIUrl":"10.1016/j.actpha.2024.07.004","url":null,"abstract":"<div><div>L’administration d’une forte dose de méthylprednisolone dans le cadre d’une poussée de sclérose en plaques induit une immunosuppression qui contre-indique l’injection de vaccins vivants atténués tels que Zostavax® pendant trois mois. Le pharmacien doit systématiquement contrôler les antécédents des personnes souhaitant recevoir des vaccins vivants atténués à l’officine afin de vérifier l’absence de traitement immunosuppresseur antérieur.</div></div><div><div>The administration of a high dose of methylprednisolone in the context of a multiple sclerosis relapse induces immunosuppression, which contraindicates the injection of live attenuated vaccines such as Zostavax® for three months. Pharmacists should systematically check the medical history of people wishing to receive live attenuated vaccines at the pharmacy, to verify the absence of previous immunosuppressive treatment.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vers une meilleure protection de la santé des patients contre les effets de la chaleur : résultats d’une enquête auprès des pharmaciens d’officine 更好地保护病人健康免受高温影响：配药药剂师调查结果
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.005
{"title":"Vers une meilleure protection de la santé des patients contre les effets de la chaleur : résultats d’une enquête auprès des pharmaciens d’officine","authors":"","doi":"10.1016/j.actpha.2024.07.005","DOIUrl":"10.1016/j.actpha.2024.07.005","url":null,"abstract":"<div><div>En complément des dispositifs de prévention et de gestion des risques sanitaires déployés par les institutions en cas de fortes chaleurs, le pharmacien d’officine doit se positionner comme un acteur de santé de premier recours afin de protéger mieux encore la santé de ses patients. Il peut adapter ses pratiques officinales et alerter spécifiquement les patients qui prennent un traitement à risque pouvant notamment aggraver une déshydratation ou altérer la thermorégulation de l’organisme. Il est aussi toujours utile de rappeler les bons gestes à adopter en cas d’épisode caniculaire et ce, plus particulièrement aux personnes vulnérables.</div></div><div><div>Towards a better protection of patients against health risks related to heat waves: Results from a survey of community pharmacists. In addition to national prevention and management systems for health risks related to heat waves, community pharmacists have a key role in primary health care to play in order to better protect patients’ health. Indeed, they can adapt pharmacy practices and specifically alert patients taking an at-risk treatment that could for instance worsen dehydration or alter thermoregulation. They should also remind people, and more particularly the most vulnerable ones, what to do in case of heat wave.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On vous demande, sachez répondre 我们在问你，所以要知道如何回答
IF 0.1
Actualites Pharmaceutiques Pub Date : 2024-09-20 DOI: 10.1016/j.actpha.2024.07.003
{"title":"On vous demande, sachez répondre","authors":"","doi":"10.1016/j.actpha.2024.07.003","DOIUrl":"10.1016/j.actpha.2024.07.003","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":null,"pages":null},"PeriodicalIF":0.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信